Biopharmaceuticals
News Release - May 21, 2007
Data Suggest that PEGASYS(R) May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron(R)
Source: Roche Group
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.